Inmode Stock Today

INMD Stock  USD 18.31  0.15  0.81%   

Performance

Weak

 
Weak
 
Strong

Odds Of Distress

Low

 
High
 
Low
InMode is trading at 18.31 as of the 16th of March 2025, a 0.81 percent decrease since the beginning of the trading day. The stock's lowest day price was 17.68. InMode has only a 6 % chance of going through financial distress over the next few years but had a somewhat weak performance during the last 90 days. Note, on March 2, 2020, Representative Tom Rice of US Congress acquired under $15k worth of InMode's common stock.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company has 69.56 M outstanding shares of which 6.13 M shares are currently shorted by private and institutional investors with about 6.9 trading days to cover. More on InMode

Moving together with InMode Stock

  0.62BAX Baxter InternationalPairCorr

Moving against InMode Stock

  0.78EMBC Embecta CorpPairCorr
  0.76WST West PharmaceuticalPairCorr
  0.57SRDX SurModicsPairCorr
  0.51SMLR Semler ScientificPairCorr
  0.49TELA Tela Bio Earnings Call This WeekPairCorr
  0.46DXR DaxorPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

InMode Stock Highlights

CEO CoFounderMoshe Mizrahy
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Financial Strength
InMode (INMD) is traded on NASDAQ Exchange in USA. It is located in Tavor Building, Yokne'am, Israel, 2069206 and employs 599 people. InMode is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.27 B. InMode conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 69.56 M outstanding shares of which 6.13 M shares are currently shorted by private and institutional investors with about 6.9 trading days to cover. InMode currently holds about 486.39 M in cash with 132.66 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.91.
Check InMode Probability Of Bankruptcy
Ownership Allocation
InMode has a total of 69.56 Million outstanding shares. Over half of InMode's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. On March 2, 2020, Representative Tom Rice of US Congress acquired under $15k worth of InMode's common stock.
Check InMode Ownership Details

InMode Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. InMode market risk premium is the additional return an investor will receive from holding InMode long position in a well-diversified portfolio.

InMode Stock Against Markets

InMode Corporate Management

When determining whether InMode is a strong investment it is important to analyze InMode's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact InMode's future performance. For an informed investment choice regarding InMode Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMode. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade InMode Stock refer to our How to Trade InMode Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMode. If investors know InMode will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMode listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of InMode is measured differently than its book value, which is the value of InMode that is recorded on the company's balance sheet. Investors also form their own opinion of InMode's value that differs from its market value or its book value, called intrinsic value, which is InMode's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMode's market value can be influenced by many factors that don't directly affect InMode's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMode's value and its price as these two are different measures arrived at by different means. Investors typically determine if InMode is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMode's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.